Comment on FR Doc # 2011-21012

Document ID: IRS-2011-0025-0007
Document Type: Public Submission
Agency: Internal Revenue Service
Received Date: November 14 2011, at 12:00 AM Eastern Standard Time
Date Posted: November 15 2011, at 12:00 AM Eastern Standard Time
Comment Start Date: August 18 2011, at 12:00 AM Eastern Standard Time
Comment Due Date: November 16 2011, at 11:59 PM Eastern Standard Time
Tracking Number: 80f6bdaa
View Document:  View as format xml

This is comment on Proposed Rule

Branded Prescription Drug Fee

View Comment

Please see the attached document, which contains Genentech's comments in response to this proposed regulation.

Attachments:

Final Comment Letter - Branded Prescription Drug Fee - 11-16-2011

Title:
Final Comment Letter - Branded Prescription Drug Fee - 11-16-2011

View Attachment: View as format pdf

Related Comments

    View All
Total: 17
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/14/2011     ID: IRS-2011-0025-0006

Nov 16,2011 11:59 PM ET
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/15/2011     ID: IRS-2011-0025-0007

Nov 16,2011 11:59 PM ET
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/16/2011     ID: IRS-2011-0025-0009

Nov 16,2011 11:59 PM ET
Comment on FR Doc # 2011-21012
Public Submission    Posted: 11/16/2011     ID: IRS-2011-0025-0011

Nov 16,2011 11:59 PM ET
Branded Prescription Drug Fee
Public Submission    Posted: 11/16/2011     ID: IRS-2011-0025-0012

Nov 16,2011 11:59 PM ET